Primary Site >> Colorectal Cancer
Gene >> REV3L
|
|
|
|
|
|---|---|---|---|---|
|
Ref: DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. PMID: 16428501 Ref: DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance. PMID: 16731756 |
Ref: Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. PMID: 18622427 |
Ref: [Roles of REV3 in proliferation and genomic stability of colon carcinoma cells]. PMID: 20466635 |
Ref: The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. PMID: 27165003 |
Ref: MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L. PMID: 29435169 |